Research programme: ion channel modulators - DyNAbind GmbH/Salipro Biotech
Latest Information Update: 19 Mar 2024
At a glance
- Originator DyNAbind GmbH; Salipro Biotech
- Class Small molecules
- Mechanism of Action Ion channel modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Unspecified